Sex Differences in the Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists for Weight Reduction: A Systematic Review and Meta‐Analysis
Chinese Academy of Medical Sciences & Peking Union Medical College · Peking Union Medical College Hospital
Abstract
To verify sex differences of GLP-1RAs for weight reduction.
We searched RCTs reporting weight change by sex from PubMed, Web of Science, Embase, Cochrane Library, and ClinicalTrials registries. Meta-regression was performed to evaluate the association between weight reduction and sex differences. Subgroup analyses were stratified by individual GLP-1RA medications, dose, treatment duration, indication, type of control, background treatment, and baseline weight. The study protocol was registered (CRD42023480167).
Citation impact
- FWCI
- 69.57
- Percentile
- 100%
- References
- 49
Authors
12- YYYucheng Yang
Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital
- LHLiyun He
Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital
- SHShumeng Han
Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital
- NYNa Yang
Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital
- YLYiwen Liu
Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital
Topics & keywords
- Exenatide
- Medicine
- Liraglutide
- Weight loss
- Dulaglutide
- Subgroup analysis
- Semaglutide
- Meta-analysis
- Good health and well-being